Ligand validation:6AY3

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6AY3_EDO_B_1202	51%	81%	0.142	0.896	0.38	0.43	-	-	0	0	100%	0.78
6AY3_EDO_A_1202	9%	63%	0.155	0.637	0.37	1.03	-	-	0	0	100%	1
5LPK_EDO_B_1203	97%	87%	0.068	0.98	0.59	0.13	-	-	0	0	100%	1
3P1F_EDO_A_1	91%	71%	0.077	0.963	0.48	0.62	-	-	0	0	100%	1
5NU5_EDO_A_1205	45%	83%	0.109	0.838	0.46	0.32	-	-	0	0	100%	1
7KPY_EDO_B_1201	42%	77%	0.136	0.856	0.5	0.41	-	-	0	0	100%	1
4NYW_EDO_A_1204	35%	66%	0.188	0.874	0.53	0.76	-	-	1	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
3G7R_EDO_B_961	100%	85%	0.035	0.988	0.45	0.3	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.